MedPath

Exploration of Management Model and Intervention Research on Fear of Cancer Recurrence

Not Applicable
Not yet recruiting
Conditions
Cancer Patients
Registration Number
NCT05922423
Lead Sponsor
Nanfang Hospital, Southern Medical University
Brief Summary

1. Through cross-sectional investigation and research, construct an fear of cancer recurrence warning model to identify and screen high fear of cancer recurrencecancer populations, in order to identify predictive factors for high fear of cancer recurrence, study how cancer patients develop susceptibility to fear of cancer recurrence during the diagnosis and treatment process, including which participating factors, explore the development trajectory of fear of cancer recurrence, and effectively prevent the occurrence of high-level fear of cancer recurrence.

2. Through randomized controlled trials, conduct a study on mindfulness and stress reduction psychosocial intervention for high-level fear of cancer recurrence patients, verify the effectiveness of psychosocial intervention measures targeting domestic cancer populations, and improve standardized intervention methods, intervention time, and treatment content.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Adults aged ≥ 18 years old
  • Consistent with pathological diagnosis of cancer
  • Able to understand and comply with research protocols
  • Written informed consent can be provided
  • Own and know how to use smart ·terminals (such as smartphones, tablets, computers, etc.)
Exclusion Criteria
  • Patients with mental illness and consciousness disorders;
  • Patients with cancer metastasis or recurrence
  • End of life treatment for patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Fear of cancer recurrence3 months

Fear of cancer recurrence after three months of intervention

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.